Peloni: “Under no circumstances should we discuss stopping AstraZeneca vaccination”

“There is no discussion about stopping the vaccination of AstraZeneca. It is safe and effective, ”government spokesman Aristotelius Peloni quoted yesterday’s statement from the European Medicines Agency (EMA) as speaking at the Open TV channel’s morning show, noting“ that the benefits outweigh the risks. ” A government spokeswoman cited the example of the UK, where 18.1 million doses of AstraZeneca vaccine have been used and only 30 cases of thrombosis have been reported. However, she said the average efficacy of the AstraZeneca vaccine is 93%, noting that some age groups are generally reluctant to take vaccines. When asked what will happen to those who have already received the first dose if an age limit is imposed on AstaZeneca vaccine, a government official replied that “if a decision is made to limit the age, it will not apply to those who already received the first dose. ” Regarding the Russian Sputnik V vaccine, Ms Peloni replied that Greece follows the instructions of the European Medicines Agency and receives only approved vaccines. AstraZeneca Concerns – National Vaccine Committee Decisive Meeting Today Questions about the AstraZeneca COVID-19 vaccine have emerged following numerous reports of thrombosis following the vaccine’s introduction. The National Vaccine Committee will meet on Friday (09/04), with many EU members and the US already known to have suspended the use of the AstraZeneca vaccine, despite the EMA announcement. At today’s meeting of the National Vaccination Committee, which tracks all scientific data, no major changes in the country’s vaccination program are expected, Marios Themistokleous, secretary general of primary health care, explained in recent statements. He added that there is no question of stopping the vaccination of AstraZeneca in any European country, stressing that it is about age restrictions. EMA stated, that the AstraZeneca vaccine must be accompanied by a warning of the risk of thrombosisas one of the very rare side effects of the drug. However, EU member states have not adopted a uniform line, and some have suspended the use of the AstraZeneca vaccine in people over a certain age. Regarding examples of countries where vaccination is restricted, it is worth noting that in Germany, Spain, Italy, the Netherlands and Estonia, the AstraZeneca vaccine has been “frozen” for persons under 60 years of age. In addition, in France and Belgium, the vaccine is administered only to people over 55 years old, while in Finland it is recommended only to people over 65 years old. AstraZeneca vaccination has also been suspended in Denmark. According to the European Medicines Agency, women under the age of 60 are at highest risk of thrombosis. Dangerous side effects can appear within 2 weeks after the AstraZeneca vaccination. As of March 22, more than 60 cases of blood clots were registered in those who received the vaccine, of which 18 were deaths. At the same time, over 25 million European citizens have already received the AstraZeneca vaccine.

Read also: Family of man with stroke after vaccination sues AstraZeneca

What EMA Reports on Thrombosis Following the announcement of the AstraZeneca vaccine and a “possible link” to reported cases of thrombosis, the EMA on Thursday (04/08) began updating its product information. In particular, in relevant document The EMA now includes thrombosis as a warning and precautionary statement. According to the EMA, the problem refers to “a very rare case of thrombosis, often in unusual locations, such as: brain, intestine, liver, spleen, combined with low platelet counts, in some cases bleeding” that have been observed after vaccination with Vaxzevria (new name AstraZeneca vaccines). The EPA also notes that “most of these cases occurred within the first 14 days after vaccination and mainly in women under 60 years of age.” In fact, the agency reports that “some incidents have resulted in death.” In its guidelines, the EMA recommends that you exercise caution and seek immediate medical attention if any of the following symptoms occur after the vaccine is given: Shortness of breath. Chest pain. Swelling in the legs. Constant abdominal pain. Medical supervision is also recommended if, after vaccination, persistent or for several days headaches, blurred vision, skin bruises, irritations in the area of ​​vaccine administration occur. …



Source link